Latest News about ICPT
Recent news which mentions ICPT
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
February 13, 2024
From Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
October 26, 2023
From Benzinga
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
October 19, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
From Benzinga
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today
September 26, 2023
Tickers
ICPT
From Motley Fool
Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
September 26, 2023
Tickers
ICPT
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
From Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
From Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
From Benzinga
Dow Tumbles 150 Points; US House Prices Rise in July
September 26, 2023
From Benzinga
Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?
September 26, 2023
Tickers
ICPT
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
From Benzinga
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 22, 2023
From Benzinga
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
From Benzinga
Why CymaBay Therapeutics Stock Is Jumping Today
September 08, 2023
From Motley Fool
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
July 13, 2023
From Benzinga
From Benzinga
From Benzinga
FDA Strikes Out Intercept Pharma's Obeticholic Acid Application For NASH Patients, Focus Shifts To Rare Liver Diseases
June 23, 2023
Tickers
ICPT
From Benzinga
New Data Shows Intercept's Fixed Dose Obeticholic Acid Combo Normalize Multiple Biomarkers In Liver Disease
June 07, 2023
Tickers
ICPT
From Benzinga
Top 5 Health Care Stocks That Could Blast Off In May
May 26, 2023
From Benzinga
From Motley Fool
The Rising Challenge for Intercept Pharmaceuticals: Analyst Downgrade Amid Ocaliva's DILI Concerns
May 23, 2023
Tickers
ICPT
From Benzinga
From Benzinga